A detailed history of Creative Planning transactions in Haemonetics Corp stock. As of the latest transaction made, Creative Planning holds 4,198 shares of HAE stock, worth $356,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,198
Previous 4,445 5.56%
Holding current value
$356,494
Previous $367,000 8.17%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$72.45 - $91.58 $17,895 - $22,620
-247 Reduced 5.56%
4,198 $337,000
Q2 2024

Aug 15, 2024

BUY
$81.24 - $97.37 $361,111 - $432,809
4,445 New
4,445 $367,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.